Definitive Healthcare vs Komodo Health: Which Platform Is Right for Your Team?
Definitive Healthcare and Komodo Health solve different problems. Definitive Healthcare is a fit when your team needs healthcare organization and account intelligence such as hospital profiles, IDN relationships, technology installs, and procedure volumes. Komodo Health is a fit when your team needs patient-level analytics to study diagnosis, treatment pathways, and patient movement across payers using de-identified real-world data.
We compares their data, use cases, integrations, pricing considerations, and trade-offs for US healthcare go-to-market teams. It also explains when a separate contact-data platform may be useful.
Key Takeaways
- Definitive Healthcare is organized around the account (hospital, IDN, physician group); Komodo Health is organized around the patient journey.
- Komodo is particularly relevant to life sciences analytics, market access, and real-world evidence teams; Definitive is relevant to teams assessing healthcare organizations and provider accounts.
- Treat pricing as quote-based until each vendor confirms scope, licensing, and contract terms.
- If your main gap is verified contact details for outreach, evaluate a contact-data platform separately rather than treating it as a replacement for either analytics platform.
Definitive Healthcare vs Komodo Health: Side-by-Side Comparison
Use this as a starting point, not a substitute for a scoped demo: the platforms’ data units and outputs differ, so their headline coverage figures are not directly comparable. Confirm availability, freshness, and licensing for the exact data you need.
| Comparison area | Definitive Healthcare | Komodo Health |
|---|---|---|
| Best for | Medtech, healthtech, and provider strategy teams selling to hospitals and health systems | Life sciences commercial, medical affairs, market access, and RWE teams |
| Core data | HospitalView listing reports about 9,300 hospital and health system profiles; check coverage definitions and date with the vendor | Healthcare Map is described by Komodo as containing 330M+ de-identified patient journeys; this is a patient-journey figure, not a facility count |
| Data types | Organization profiles, affiliations, technology installs, financials, all-payor medical and prescription claims | Claims, insurance coverage, EHR, genomics, and race and ethnicity data linked at the patient level |
| Provider view | Physician and physician-group profiles and referral/affiliation information, depending on product and license | HCP segmentation and patient analytics; confirm provider-level fields and geography in scope |
| Affiliations | Parent and child IDN relationships, network members | Patient flow across providers and payers |
| Contact fields | Executive contacts in hospital and network profiles | Not a focus of Komodo’s public product descriptions; confirm with the vendor |
| Analytics tools | Platform search, dashboards, and reports | MapLab suite (MapView, MapExplorer, MapAI) and the Marmot AI engine |
| CRM and delivery | Salesforce-embedded connector has been described in company materials; confirm current availability and license | Databricks Marketplace / Delta Sharing is a data-delivery route, not a direct CRM integration equivalent |
| Pricing and contracts | Quote-based; annual enterprise subscriptions | Quote-based; enterprise agreements |
| Potential limitation to evaluate | May not provide the depth of patient-journey analytics your use case requires | Public product materials emphasize analytics; verify whether your license includes the specific contact fields and rep workflows you need |
What Is Definitive Healthcare?
Definitive Healthcare sells subscription access to data and analytics on healthcare organizations, providers, and claims. For commercial teams, its value is understanding the organization behind a target account before prioritizing outreach.
Confirmed Capabilities
- HospitalView: about 9,300 hospital and health system profiles built from nearly 40 public, private, and proprietary sources.
- Profile data: parent and child system relationships, technology installs by vendor and product, diagnosis and procedure claims, and financial metrics such as bed counts (same source).
- Claims: all-payor medical and prescription claims, per Definitive Healthcare’s product pages.
- CRM workflow: a Salesforce-embedded connector, which the company highlighted in its Q2 2026 results.
Our Read on Strengths and Limitations
Definitive Healthcare is strongest when the purchase happens at the system level. A device team selling to IDNs in Texas can rank hospitals by procedure volume, and a healthtech team can filter for hospitals running Epic. It is designed around organization and provider intelligence rather than the patient-journey analysis that is central to Komodo’s offering.
Ideal buyer: a VP of Sales or strategy lead at a medtech or healthtech company selling to hospitals, IDNs, and ASCs.
Vendor note: As of the SEC filing reviewed for this draft on October 13, 2026, Definitive Healthcare had disclosed a non-binding proposal from Advent International to take the company private (SEC filing). A proposal is not a completed transaction. Recheck the latest filings before publication and ask the vendor about any implications for contract continuity and the product roadmap.
What Is Komodo Health?
Komodo Health is a healthcare analytics company founded in 2014. Its Healthcare Map brings together de-identified, patient-level real-world data for teams studying patient populations and treatment pathways. Verify current corporate and location details before publication if they are material to the article.
Confirmed Capabilities
- Healthcare Map: more than 330 million de-identified patient journeys, combining claims, insurance coverage, EHR, genomics, and race and ethnicity data (MapLab launch release).
- MapLab: an analytics suite that includes MapView (pre-built modules for market and disease landscaping, patient and HCP segmentation, and brand performance), MapExplorer (no-code population exploration), and MapAI (a conversational analytics assistant) (September 2024 release).
- Marmot: an AI engine launched in August 2025 that returns analyses with auditable code and a separate review agent (August 2025 release).
- Data delivery: Healthcare Map access through Databricks Marketplace and Delta Sharing (April 2025 release).
- Customers: Komodo reported more than 200 life sciences and healthcare organizations using its products as of September 2024, including Johnson & Johnson, Merck, and Takeda (September 2024 release). This is a dated figure; do not present it as a current customer count.
Our Read on Strengths and Limitations
Komodo is strongest when the question is about patients: how many are diagnosed with a condition in a region, which HCPs treat them, and where they go next. A biopharma brand team in oncology or rare disease gets the most from it. Its public product descriptions emphasize analytics and segmentation. If your sales team also needs verified work emails, direct dials, or other outreach fields, confirm what is included in the proposed license rather than assuming those fields are absent.
Ideal buyer: a commercial analytics, brand, medical affairs, or real-world evidence leader at a pharmaceutical or biotech company.
Which Platform Fits Which Use Case?
Start with the decision your team needs to make. Account intelligence, patient-journey analytics, and outreach contact data are different jobs and may require separate tools.
Quick decision guide
- Need to prioritize hospitals, IDNs, and provider organizations? Evaluate Definitive Healthcare.
- Need to analyze patient populations, treatment pathways, or real-world evidence? Evaluate Komodo Health.
- Already know which accounts or NPIs to target, but lack usable contact details? Test a contact-data and enrichment platform alongside your analytics tool.
| Your situation | Better fit | Why |
|---|---|---|
| Biopharma brand team sizing a rare disease population and finding treating HCPs in the Northeast | Komodo Health | Patient-level journeys and HCP segmentation |
| Market access team tracking how patients move across payers after a launch | Komodo Health | Linked claims and insurance coverage data |
| Medtech team selling capital equipment to IDNs in Texas and Florida | Definitive Healthcare | IDN hierarchies, technology installs, procedure volumes |
| Health system business development team mapping referral leakage in Ohio | Definitive Healthcare | Referral and affiliation views across physicians and facilities |
| Healthtech startup selling to independent practices in Arizona | Test an outreach-focused platform | Needs practice-owner contacts and verified emails at a smaller commitment |
Why Practice Ownership and System Affiliation Matter
The clinician treating a patient is not always the person who approves a purchase. Check whether the data you license identifies practice ownership and parent-system affiliation at the level your sales process requires; do not assume either vendor includes every field in every package.
- Fewer independent physicians: 42.2% of US physicians were in private practice in 2024, down from 60.1% in 2012 (AMA). What to do: separate practice owners, who buy, from employed physicians, who influence.
- More hospital and PE ownership: 34.5% of physicians worked in hospital-owned practices and 6.5% in private equity-owned practices in 2024 (Fierce Healthcare, reporting AMA data). What to do: map each practice to its parent system before you assign it to a rep.
- System-level hospital buying: about two-thirds of the 5,121 US community hospitals are system-affiliated (AHA Fast Facts 2026). What to do: find the supply chain, IT, or service line leader on the system’s value analysis committee.
Patient-level analytics can help identify where demand may exist. Account and contact data can then help commercial teams identify the organizations and decision-makers relevant to that opportunity.
Pricing, Contracts, and an Evaluation Checklist
There is no public list pricing available for either platform. Request a quote based on your intended modules, users, geography, data rights, and delivery method. For additional context on Definitive Healthcare, see our guide to Definitive Healthcare pricing.
Compare cost per record or analysis your team will actually use. For Definitive, test a sample against your target accounts and required organization fields. For Komodo, scope an analysis in one therapeutic area and geography, then assess whether the output and workflow suit your team’s analytical capabilities.
Use these questions on every evaluation call:
- Is the data organized around accounts, providers, or patients, and which does my sales motion need?
- How often is each data type refreshed, and what is the lag on claims data?
- Can I filter physicians by practice ownership and map them to a parent system?
- Which contact fields (work email, direct dial, LinkedIn) are in my license, if any?
- Does the data push into our CRM or data warehouse, and who maintains the integration?
- Can I upload my CRM list or NPI file and suppress records I already have before I pay?
- What is the contract length, auto-renewal term, and exit clause, including after a change of vendor ownership?
When to Consider an Outreach-Focused Healthcare Data Platform
Consider an outreach-focused platform when your bottleneck is reaching the right practice owner, practice manager, or hospital executive, not sizing a market or a patient population. Ampliz is a B2B commercial healthcare data provider built for that workflow: identify, enrich, segment, and activate.
Teams that benefit most: healthtech companies selling to clinics and physician groups, medical device teams targeting ASCs and independent practices, healthcare staffing and recruiting firms, and healthcare marketing agencies running campaigns for clients.
Workflows the platform supports:
- HCP Lookup covers 6.8M+ healthcare providers. Filter by specialty, sub-specialty, CPT and HCPCS procedure codes, and practice ownership to reach owners, not employed physicians.
- Executive Search covers 11M+ healthcare executives by title, department, seniority, facility type, bed size, and EHR vendor.
- Hospital Analytics on the Ampliz healthcare data platform shows parent IDN, GPO relationships, ACO affiliations, and each facility’s people directory.
- NPI Lookup and the Data Enrichment Engine match your existing NPI file or CRM list and fill in missing emails, phones, and LinkedIn profiles. This is useful when a patient-level analysis hands you a list of target NPIs with no contact details.
How it fits alongside these platforms: Ampliz is intended for contact discovery and enrichment, not as a replacement for Komodo’s patient-journey analytics or Definitive Healthcare’s market and account intelligence. Verify current email-verification cadence, credit policies, and compliance statements with the Ampliz product and legal owners before publication. Learn more about Ampliz as a Definitive Healthcare alternative.
What to verify in a demo: match rates on your own target accounts or NPI list, the share of records with a verified work email and direct dial, and whether the practice-ownership filter returns the owners you expect in your territory.
Check Ampliz’s contact coverage for your target accounts. Book a demo to test how many of your priority practices, physicians, and hospital decision-makers in US have usable contact details. Book a Demo
FAQs
Is Definitive Healthcare better than Komodo Health?
Neither is better across the board; they answer different questions. Definitive Healthcare is stronger for hospital and IDN account intelligence, such as affiliations, technology installs, and procedure volumes. Komodo Health is stronger for patient-level analytics, such as disease prevalence, treatment pathways, and patient flow across payers.
What is the Komodo Health Healthcare Map?
The Healthcare Map is Komodo Health’s dataset of more than 330 million de-identified patient journeys. It links claims, insurance coverage, EHR, genomics, and race and ethnicity data at the patient level. Life sciences teams use it through Komodo’s MapLab tools and Marmot AI engine for segmentation, brand performance, and real-world evidence work.
Does Komodo Health provide HCP contact data?
Komodo’s public product descriptions focus on patient-level analytics and HCP segmentation, not contact details such as verified emails or direct dials. Ask Komodo directly what is included in your license. If your analysis produces a list of target NPIs, you can enrich it with contact data from a separate provider.
Who are Komodo Health’s main competitors?
Depending on the use case, buyers may evaluate real-world data and analytics providers such as IQVIA, HealthVerity, and Symphony Health. Definitive Healthcare may also enter the shortlist when provider, claims, and account intelligence overlap with the requirement. Compare vendors against the same use case and data requirements rather than treating them as interchangeable.
Is Definitive Healthcare being acquired?
The latest filing dated September 2026, described a non-binding proposal from Advent International to take Definitive Healthcare private at $1.02 per share. That does not establish that an acquisition has been completed. Check the latest SEC filings before publication or before making a contract decision.
Definitive Healthcare vs Komodo Health: The Bottom Line
Choose based on the job to be done: evaluate Definitive Healthcare for organization and account intelligence, Komodo Health for patient-level analytics and real-world evidence, and a separate outreach-focused platform if the immediate gap is contact coverage. Before signing, test the shortlisted tools against the same target accounts, NPIs, or therapeutic-area question and compare usable coverage, data freshness, workflow fit, and total cost.
See how Ampliz covers your target accounts before you commit to an enterprise contract. Book a demo to test HCP Lookup, Executive Search, and Hospital Analytics against the practices and health systems your team sells to. Book a Demo
You May Also Like To Read
How Healthcare Market Research Can Improve Your Marketing Strategy
Introduction Healthcare marketers are under increasing pressure to prove ROI while navigating tighter budgets and